Aptevo Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.34-0.601.030.61
Price/Sales ratio
N/A0.720.160.12
Earnings per Share (EPS)
$-5.77$-3.26$1.9$3.22

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-117.14-100.95-16.25480.00-19.69-24.45-249.25-49.9710.29-4.700.34-19.69
Price/Sales ratio
131.22178.2150.15228.3445.8330.501.06K111.05141.12N/A3.0630.50
Price/Book Value ratio
63.2967.5736.1340.8034.7783.51277.101.12K24.456.700.5383.51
Price/Cash Flow ratio
-127.38-122.80-49.56-80.51-20.56-23.33-156.84-62.96-20.90-6.98-0.32-20.56
Price/Free Cash Flow ratio
-124.76-119.07-46.40-77.88-20.17-23.24-156.37-60.96-20.87-6.98-0.32-20.17
Price/Earnings Growth ratio
28.12-6.29-0.18-6.62-0.350.414.10-7.05-0.040.040.01-0.35
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
64.37%49.60%33.62%65.82%51.38%38.54%-314.29%-54.52%71.06%N/AN/A38.54%
Operating Profit Margin
-112.84%-181.83%-348.42%-368.05%-223.97%-126.33%-638.05%-174.09%-919.74%N/A-1342.77%-126.33%
Pretax Profit Margin
-113.33%-182.54%-350.64%-381.31%-232.75%-132.81%-717.63%-239.24%225.24%N/A867.05%-232.75%
Net Profit Margin
-112.01%-176.53%-308.54%47.57%-232.75%-124.74%-428.12%-222.20%1370.23%N/A877.55%-232.75%
Effective Tax Rate
1.15%3.29%12.00%41.68%3.76%6.07%40.34%7.12%-508.34%N/AN/A6.07%
Return on Assets
-42.60%-52.74%-122.37%5.95%-79.54%-75.73%-34.45%-48.25%124.70%-70.08%79.86%-79.54%
Return On Equity
-54.02%-66.93%-222.31%8.5%-176.57%-341.56%-111.17%-2246.13%237.39%-142.46%214.75%-176.57%
Return on Capital Employed
-51.42%-66.04%-175.54%-54.77%-103.57%-270.03%-70.48%-97.96%-112.27%-163.91%-163.91%-270.03%
Liquidity Ratios
Current Ratio
N/AN/A3.655.132.760.783.25N/AN/AN/A3.152.76
Quick Ratio
1.200.743.315.082.660.622.921.422.972.632.592.59
Cash ratio
0.180.230.490.381.730.322.741.292.592.332.591.73
Days of Sales Outstanding
121.0285.073.0753.3182.59N/A200.66108.79293.03N/AN/AN/A
Days of Inventory outstanding
395.78438.05100.2074.8958.09112.4497.7959.22636.42N/AN/A112.44
Operating Cycle
516.81523.12103.28128.20140.69112.44298.46168.02929.45N/AN/A112.44
Days of Payables Outstanding
257.61217.36158.75535.47379.87117.74114.1466.521.41K2.56KN/A117.74
Cash Conversion Cycle
259.19305.76-55.47-407.27-239.17-5.29184.31101.49-488.01N/AN/A-239.17
Debt Ratios
Debt Ratio
N/AN/A0.200.160.280.370.460.270.10N/A0.470.28
Debt Equity Ratio
N/AN/A0.360.230.631.671.5012.640.19N/A0.900.63
Long-term Debt to Capitalization
N/AN/A0.260.160.38N/A0.540.750.07N/A0.29N/A
Total Debt to Capitalization
N/AN/A0.260.180.380.620.600.920.16N/A0.340.62
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/A-2.00-2.18-2.66-2.13-1.17-1.41-6.08N/A-3.06-2.13
Company Equity Multiplier
1.261.261.811.422.214.513.2246.541.902.031.904.51
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-1.03-1.45-1.01-2.83-2.22-1.30-6.80-1.76-6.75N/A-9.37-1.30
Free Cash Flow / Operating Cash Flow Ratio
1.021.031.061.031.011.001.001.031.0011.001.00
Cash Flow Coverage Ratio
N/AN/A-2.00-2.18-2.66-2.13-1.17-1.41-6.08N/A-3.06-2.13
Short Term Coverage Ratio
N/AN/AN/A-12.47N/A-2.13-5.86-1.85-10.51N/A-14.60-2.13
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A